Evidence map›Paper›PMID 25482636›Full record

ReviewCell adhesion & migration2014

Regulation of signaling interactions and receptor endocytosis in growing blood vessels.

Mara E Pitulescu, Ralf H Adams

Open access · goldAbstract readReview
In one paragraph

Review in Cell adhesion & migration, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
1.2field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 52 citations in OpenAlex.

  1. Genetic determinants of insufficiency of the collateral circulation.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2026
    Review
  2. GlialeLife · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. VEGFR1 signaling in retinal angiogenesis and microinflammation.Progress in retinal and eye research · 2021
    Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Mara E Pitulescua Department of Tissue Morphogenesis; Max Planck Institute for Molecular Biomedicine; and Faculty of Medicine , University of Münster ; Münster , Germany.
Ralf H Adams
Max Planck Society · DEUniversity of Münster · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Blood vessels and the lymphatic vasculature are extensive tubular networks formed by endothelial cells that have several indispensable functions in the developing and adult organism. During growth and tissue regeneration but also in many pathological settings, these vascular networks expand, which is critically controlled by the receptor EphB4 and the ligand ephrin-B2. An increasing body of evidence links Eph/ephrin molecules to the function of other receptor tyrosine kinases and cell surface receptors. In the endothelium, ephrin-B2 is required for clathrin-dependent internalization and full signaling activity of VEGFR2, the main receptor for vascular endothelial growth factor. In vascular smooth muscle cells, ephrin-B2 antagonizes clathrin-dependent endocytosis of PDGFRβ and controls the balanced activation of different signal transduction processes after stimulation with platelet-derived growth factor. This review summarizes the important roles of Eph/ephrin molecules in vascular morphogenesis and explains the function of ephrin-B2 as a molecular hub for receptor endocytosis in the vasculature.

Indexed as

Signal TransductionAnimalsBlood VesselsEndocytosisEndothelial CellsEphrin-B2FibrosisHumansKidneyMiceMorphogenesisNeovascularization, PathologicNeovascularization, PhysiologicReceptor, EphB4Receptor, Platelet-Derived Growth Factor betaReceptor Protein-Tyrosine KinasesEphrin-B2Receptor, EphB4Receptor, Platelet-Derived Growth Factor betaReceptor Protein-Tyrosine KinasesVascular Endothelial Growth Factor Receptor-2Ang, angiopoietinaPKC, atypical protein kinase CCHC, clathrin heavy chainsCLASP, clathrin-associated-sorting proteinCV, cardinal veinDA, dorsal aortaEC, endothelial cellEEA1, early antigen 1endocytosisendothelial cellsEphephrinEphrin-B2ΔV, ephrin-B2 deletion of C-terminal PDZ binding motifHSPG, heparan sulfate proteoglycanJNK, c-Jun N-terminal kinaseLEC, lymphatic endothelial cellsLRP1, Low density lipoprotein receptor-related protein 1mural cellsMVB, multivesicular bodyNRP, neuropilinPC, pericytesPDGF, platelet-derived growth factorPDGFR, platelet-derived growth factor receptorPlGF, placental growth factorPTC, peritubular capillaryreceptorRTK, receptor tyrosine kinaseVEGFR, Vascular endothelial growth factor receptorVEGF, Vascular endothelial growth factorVSMC, vascular smooth muscle cells.

Identifiers

PMID25482636
PMCPMC4594521
OpenAlexW2006464201

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.